Archive | prostate cancer RSS for this section

Aggressive treatment of early stage prostate cancer doesn’t save lives

Prostate cancer is the second-leading killer of men, with more than 240,000 new diagnoses and 28,000 deaths every year. While many doctors still screen for the disease, more and more medical organizations are recommending against routinely doing so. And even with a cancer diagnosis, it’s not clear that aggressive treatments such as surgery or radiation […]

Share
Continue Reading

When it comes to healthcare newer doesn’t always mean better

It has been shown that the development and marketing of newer and more expensive technologies drives up healthcare costs. Every day newer and more expensive devices are manufactured, marketed and purchased by doctors and hospitals across the USA. Although many of these improve care, there are a significant number of them that add little to […]

Share
Continue Reading

Comparing treatments for prostate cancer between countries is like comparing apples to oranges

A study reported in the New England Journal of Medicine and reported on NPR appears to justify surgery for men with “low risk” prostate cancer. However, more careful review of the article revealed that what the Swedes define as “low risk” may be given a “higher risk” diagnosis in the United States. If we used […]

Share
Continue Reading

Financial incentives financially drive prostate cancer treatment

A couple of years ago the New England Journal of Medicine reported that many men with prostate cancer were being inappropriately treated with drugs that in effect castrate men. It’s called androgen deprivation therapy (ADT). The standard of care in prostate cancer is that only men with incurable disease be treated with ADT. So then, […]

Share
Continue Reading

PSA Still Fails to Reduce Deaths from Prostate Cancer

Last October, the results of the PLCO trial to determine the effectiveness of PSA screening were released. After a follow-up of 7 to 10 years, screening asymptomatic men for prostate cancer with PSA didn’t save more lives when compared with a group of men who were given routine medical care and tested for prostate cancer […]

Share
Continue Reading